Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001950047-24-008120
Filing Date
2024-11-05
Accepted
2024-11-05 16:33:59
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 3227
  Complete submission text file 0001950047-24-008120.txt   4755
Mailing Address 1000 SPRING ST SILVER SPRING MD 20910
Business Address 1000 SPRING ST SILVER SPRING MD 20910 3016089292
UNITED THERAPEUTICS Corp (Subject) CIK: 0001082554 (see all company filings)

EIN.: 521984749 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 000-26301 | Film No.: 241428038
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O UNITED THERAPEUTICS CORPORTION 1735 CONNECTICUT AVE. NW WASHINGTON DC 20009
Business Address
Giltner Richard (Reporting) CIK: 0001460472 (see all company filings)

Type: 144